Background Central Australia has the highest recorded prevalence of infection with the
human T cell leukaemia virus type 1 (HTLV-1) worldwide. Each of the clinical diseases …

Infection with the human T cell leukaemia virus type 1 (HTLV-1) subtype C is endemic
among Aboriginal people in central Australia. To provide insights into the risk factors for …

Abstract Background The Human T Lymphotropic Virus type 1 (HTLV-1) subtype C is
endemic to central Australia where each of the major sequelae of HTLV-1 infection has been …

Abstract Background Central Africa is one of the largest areas of high endemicity for human
T-cell leukemia virus-1 (HTLV-1). However, no preventive measures are yet implemented to …

Introduction In resource-poor areas, infectious diseases may be important causes of
morbidity among individuals infected with the Human T-Lymphotropic Virus type 1 (HTLV-1) …

Human T-cell leukaemia virus type 1 (HTLV-1) is an oncogenic retrovirus that affects as
many as 20 million people worldwide. The virus is of zoonotic origin, and it is commonly …

Background. The human T‐cell lymphotropic virus types 1 and 2 (HTLV 1/2) are retroviruses
associated with different pathologies. HTLV‐1 causes adult T‐cell leukemia/lymphoma …

Introduction Human T‐cell lymphotropic virus type 1 (HTLV‐1) is a chronic infection affecting
5–10 million people worldwide. Ten percent develop HTLV‐1‐associated diseases, and 3 …

Objectives Human T‐lymphotropic virus (HTLV)‐1 causes T‐cell leukaemia and myelopathy.
Together with HTLV‐2, it is endemic in some African nations. Seroprevalence data from …

Human T-cell lymphotropic virus type-1 (HTLV-1) has a large global burden and in some key
communities, such as Indigenous Australians living in remote areas, greater than 45% of …